Novo Nordisk on Wednesday narrowly improved its financial guidance for a year where it still sees profit and sales falling after the fastest take-up in weight-loss drug history for its Wegovy pill.
Novo Nordisk says the Wegovy pill saw the fastest take-up in weight-loss drug history
Related Posts
Popular News
Latest News
AI Bitcoin Miner Rally Shifts Focus to Governance
Several publicly traded Bitcoin miners have enjoyed sharp stock re-ratings after pivoting toward AI infrastructure, but investors are increasingly questioning...
Turkey’s Erdogan gives NATO leaders revolver conundrum after summit
Turkey’s Erdogan gives NATO leaders revolver conundrum after summit
The GoPro Max2 Is $200 Off Right Now
We may earn a commission from links on this page. Deal pricing and availability subject to change after time of...
Bank of Korea defends bank-first stablecoin plan amid bill deadlock
The Bank of Korea has reaffirmed that won-denominated stablecoins should initially be issued through bank-led consortiums, reinforcing its position as...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.